Skip to content

Carfenazine

Drug profile

Also known as: carphenazin, carphenazine, carphenazine maleate, proketazine, proketazine maleate

OfmFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Carfenazine is an ofm drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including DRD2 and HTR2A. Recorded indications include Chronic schizophrenia.

  • Approval status: ofm.
  • Molecular targets: DRD2 and HTR2A (2 listed in DrugCentral).
  • Indications: Chronic schizophrenia.
  • Molecular formula: C24H31N3O2S; molecular weight 425.59 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Chronic schizophrenia

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
D(2) dopamine receptorDRD2antagonist—
5-hydroxytryptamine receptor 2AHTR2Aantagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—WYETH AYERST

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Carfenazine is on its molecule page.

Molecular formulaC24H31N3O2S
Molecular weight425.59 g/mol
CAS number2622-30-2
InChIKeyXZSMZRXAEFNJCU-UHFFFAOYSA-N
PubChem CID18104
CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Carfenazine used for?

DrugCentral lists the following indications for Carfenazine: Chronic schizophrenia.

How does Carfenazine work?

Its molecular targets in DrugCentral include DRD2 (antagonist) and HTR2A (antagonist).

What is the chemical formula of Carfenazine?

Carfenazine has the molecular formula C24H31N3O2S and a molecular weight of 425.59 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets2
Indications1
FormulaC24H31N3O2S
DrugCentral ID516
Interactive profile